<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Regeneron Announces Positive Phase II Results for Evinacumab
Image Overlay - Regeneron Announces Positive Phase II Results for Evinacumab

Regeneron Announces Positive Phase II Results for Evinacumab

September 10, 2019

Regeneron Announces Positive Phase II Results for Evinacumab

In a trial evaluating patients with homozygous familial hypercholesterolemia, a genetically inherited form of increased LDL cholesterol, Regeneron’s drug showed a 49% decrease in LDL levels, compared with a 2% decrease for placebo. Yourway is dedicated to helping support clinical trials like this for rare disease patients.

 Back to Index
Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat
Come chat with us!
Hello! How can I help you?